Thanks FORTUNE for sharing! #BayArea #ucsf #startup Crystal Nyitray SVLC Khosla Ventures Read Fortune's Term Sheet content.fortune.com/newsletter/ter…

Expansions & Launches FDB (First Databank Inc.) launches clinical decision support #Analytics solution MindPath Care Centers & @CPsychMD announce expansion of #MentalHealth services in #Texas Encellin, a #regenerativemedicine company are developing implanted cell pouches to treat #chronicdisease

.Encellin CEO Crystal Nyitray highlights the biotech company's innovative approach to delivering cell therapy to treat chronic diseases medcitynews.com/2021/08/person… #biotech #regenerativemedicine #chronicdisease #startups

QB3 alum Crystal Nyitray is UCSF Rosenman Institute's #Healthtech Leader of the Month. CEO & co-founder of Encellin, developing cell encapsulation devices to treat chronic diseases incl. endocrine disorders rosenmaninstitute.org/healthtech-lea… @TejalDesaiUCSF The Desai Lab @ UCSF UC San Francisco

We're ending this month on a high note. Crystal Nyitray is September's #Healthtech Leader of the Month 🏆 Read more about Crystal & , Encellin: rosenmaninstitute.org/healthtech-lea… #Leadership #Medtech #MedTwitter

Encellin is a #RosenmanInnovator developing a soft "Cell Encapsulation Device" (CED) to deliver cell therapies for chronic endocrine disorders. Learn more about Encellin: rosenmaninstitute.org/portfolio/ence…

.Crystal Nyitray CEO at Encellin speaking about the company’s tech platform in #diabetes. #BioFuture21

.Crystal Nyitray CEO Encellin speaks about how to help cells survive - can deliver cell therapies and lose the majority of cells delivered in the body. How do we maintain the viability of cells after injection? #BioFuture21

At Encellin we’re focused on keeping the cells safe and humans safe. — Crystal Nyitray #BioFuture21

“YC Bio Founder Hour: Encellin, S19” with Ethan Perlstein bio/acc, Encellin, and DNA Tie Club. Saturday, Oct 23 at 11:00 AM PDT in @clubhouse! clubhouse.com/event/M66Bdrpz

Thanks BioSpace Demy Colton for letting Encellin share our vision for the future! #startups #JPMorgan #BiotechShowcase biospace.com/article/cardio…

.Encellin combines cell encapsulation technology with functional cell therapy to treat patients with chronic diseases. “We're proud of our diversity and believe it to be one of our distinct strengths,” says founder & CEO Crystal Nyitray

“We’re working towards a new kind of tool for treating diseases, enabling cell therapies.” - Grace Wei The use of cell therapy & trusting the data is what allows Encellin to redefine how chronic diseases are treated. Learn more here: bit.ly/3vw1S8H #HealthLeader

Our #RISE Program helped 5 talented entrepreneurs from underrepresented backgrounds make massive strides over the last three months. Curious how? Read our blog post by clicking the link below! rosenmaninstitute.org/blog/shining-a…

Encellin pouches $9.9m to target diabetes with cell encapsulation tech Khosla Ventures and Y Combinator back UCSF spinout developing implantable pouches that release therapeutic cells when needed. Encellin #investment #diabetes #celltherapy longevity.technology/news/encellin-…

Pleased to announce our $9.9M financing led by Khosla Ventures to advance our Encapsulated Cell Replacement Therapy (EnCRT)!! 🎉 🎉 🎉 Grateful for the support of our investors and incredible dedication of Encellin team.

Thanks Endpoints News for speaking about Encellin about our recent financing and vision for the future of living medicine!

Grateful for the continued support of Y Combinator to help Encellin advance medicine!

Thanks Y Combinator for sharing in this journey!!